Benjamin E. Schreiber - Publications

Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a cardiovascular magnetic resonance study in intermediate-high risk pulmonary arterial hypertension.

Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Published: October 29, 2025

Polymeric nanoparticles produced by electrohydrodynamic atomisation for the passive delivery of imatinib.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: April 12, 2024

Prognostic utility of exercise cardiovascular magnetic resonance in patients with systemic sclerosis-associated pulmonary arterial hypertension.

Journal: European heart journal. Cardiovascular Imaging

Published: January 01, 2024

Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.

Journal: Rheumatology (Oxford, England)

Published: November 11, 2023

Pulmonary hypertension - the latest updates for physicians.

Journal: Clinical medicine (London, England)

Published: September 29, 2023

Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.

Journal: European heart journal. Cardiovascular Imaging

Published: March 06, 2022

Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 03, 2022

Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: a single-centre experience.

Journal: Rheumatology (Oxford, England)

Published: March 20, 2021

Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement.

Journal: British journal of anaesthesia

Published: November 11, 2020

EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.

Journal: The European respiratory journal

Published: January 21, 2020

Pseudogout or pseudolymphoma? Calcium pyrophosphate deposition disease of the cervical spine: a rare presentation and literature review.

Journal: BMJ case reports

Published: December 05, 2019

Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.

Journal: British journal of pharmacology

Published: October 25, 2018